ISORDERS of serum osmolarity and fluid balance are relatively common in patients who have underlying intracranial disease. In particular, disorders of fluid balance occur in association with head trauma, subarachnoid hemorrhage, cerebral infection, and lesions of the hypothalamic-pituitary axis.
ISORDERS of serum osmolarity and fluid balance are relatively common in patients who have underlying intracranial disease. In particular, disorders of fluid balance occur in association with head trauma, subarachnoid hemorrhage, cerebral infection, and lesions of the hypothalamic-pituitary axis. 2 Following transsphenoidal resection of pituitary adenomas and other sellar lesions, patients are at increased risk for developing disorders of water balance, including central DI and SIADH. In one study, 6 transient postoperative polyuria or hyponatremia was identified in approximately half of all patients who underwent pituitary surgery. The most common postoperative endocrine complication associated with surgery in the sellar region, DI has been reported to occur in 0.5 to 80% of patients within the first few days after surgery and is usually transient. 4, 9, 11, 12, 16 Persistent DI has been reported to occur in only 1 to 15% of patients. 12 Hyponatremia secondary to SIADH is also commonly encountered following pituitary surgery, and has been reported to occur in 8 to 35% of patients. 7, 9, 13 Hyponatremia generally occurs in a more delayed fashion than transient DI, with serum sodium levels reaching their nadir on or around postoperative Day 7. 3,7,9,14 Patients who remain normonatremic throughout their postoperative course reach a relative nadir of serum sodium levels around postoperative Day 7. 6, 9 It has been postulated that aberrancies in the secretion of ADH may occur in response to surgical manipulation of the neurohypophysis, pituitary stalk, or hypothalamus, resulting in oversecretion of ADH and subsequent hyponatremia. 6 A characteristic triphasic response has been described on the basis of physiological animal models in which polyuria develops over the first 24 to 48 hours following surgery, followed by delayed hyponatremia approximately 1 week later, and finally a recurrence of persistent DI. 5, 8, 10, 15 This classic triphasic pattern has been observed to occur in approximately 1 to 2% of patients. 6, 13 Due to emerging trends in pituitary surgery toward the use of minimally invasive procedures, such as the endonasal and endoscopic transsphenoidal approaches, patients are being discharged from the hospital earlier than previously. Many patients who undergo transsphenoidal pituitary surgery are discharged home on postoperative Day 2 or 3. Because hyponatremia typically occurs in a delayed fashion, symptoms may develop insidiously, while patients are at home. Symptoms of hyponatremia generally develop only if serum sodium levels fall below 125 mEq/L, and patients may present with lethargy, headache, nausea, and vomiting. 12 Further progression of hyponatremia may result in neurological symptoms or signs, including altered mental status and seizure. Neurological symptoms and signs tend to be related to the abruptness and extent of the decline in the serum sodium level. Symptomatic patients are often hospitalized in an effort to prevent neurological complications.
There is currently no established standard of care regarding monitoring for hyponatremia in the later postoperative period, especially after discharge from the hospital. At the time of discharge, some centers request that patients notify their physicians if they begin to develop symptoms consistent with hyponatremia. Other centers, such as our own, have started to rely on objective screening measures by requesting that patients have blood drawn for immediate evaluation of serum sodium levels on an outpatient basis on postoperative Day 7. Further decisions for management can then be based on this value as well as the individual patient's clinical condition.
In this report, we present our experience with the diagnosis and management of delayed postoperative hyponatremia in a series of 369 patients who underwent transsphenoidal surgery for pituitary adenomas or other sellar lesions. Unique to this study is the monitoring of serum sodium levels in 241 outpatients 7 days following transsphenoidal surgery. We wanted to determine the potential risk factors for the development of delayed hyponatremia and to stratify these risk factors on the basis of serum sodium values.
Clinical Material and Methods
A database was created for all patients who underwent surgical resection of a pituitary adenoma or other sellar lesion at the University of Southern California University Hospital, between August 1997 and July 2004. Pertinent information, including demographic data, tumor characteristics, surgical pathological findings, complications, endocrinological data, and postoperative serum sodium levels, were routinely entered into this database. Additionally, some degree of retrospective analysis was performed for several cases with incomplete data. This study was undertaken with approval of the institutional review board and was carried out in compliance with the requirements of the Health Insurance Portability and Accountability Act.
The majority of patients underwent resection of a sellar lesion via the sublabial or transnasal transsphenoidal approach. Since 2001, we have regularly used an endonasal approach to the sellar region as opposed to the traditional sublabial transsphenoidal approach.
Upon routine discharge, patients were provided with a laboratory requisition for a "stat serum sodium level" and were asked to have blood drawn on an outpatient basis on postoperative Day 7 or sooner if symptoms consistent with hyponatremia developed. The serum sodium value was then faxed to the neurosurgery and endocrinology departmental offices for review, and was subsequently entered into the patient database. Patients with asymptomatic hyponatremia were asked to follow a fluid restriction protocol and a highsodium diet. Symptomatic patients were admitted for observation and therapy.
Delayed hyponatremia was defined as a serum sodium level of less than 135 mEq/L on or after postoperative Day 3. For 86% of the patients, a serum sodium value was obtained between postoperative Days 6 and 9. The remaining 14% of patients had serum sodium levels obtained between postoperative Days 3 and 6 or Days 9 and 13. The following stratifications of hyponatremia were used: mild hyponatremia, serum sodium level of 131-135 mEq/L; moderate hyponatremia, 126-130 mEq/L; severe hyponatremia, less than or equal to 125 mEq/L. The majority of diagnoses of symptomatic SIADH were made in conjunction with the division of endocrinology.
Statistical Analysis was carried out using GraphPad Prism statistical software (GraphPad Software, Inc.). Group means were compared using a two-tailed unpaired t-test, with a 95% confidence interval. Bimodal outcomes were compared using a two-tailed Fisher exact test, with a confidence interval of 95%. Statistical significance was defined as a probability value less than 0.05.
Results
Between August 1997 and July 2004, 422 patients underwent transsphenoidal surgical resection of a pituitary or other sellar lesion performed by one surgeon (M.H.W.) at University of Southern California University Hospital. Forty-nine patients were excluded from the study because sufficient postoperative data could not be obtained. Four patients with a previous history of DI or SIADH were also excluded from the study. The remaining 369 cases served as the basis for this study. In 241 (65%) of these cases, the patients had routine serum sodium levels drawn as outpatients on postoperative Day 7. The patient characteristics are summarized in Table 1 .
Outpatient Sodium Screening
Two hundred forty-one of the 369 patients in the study had sodium levels drawn as outpatients on postoperative Day 7. Their mean age was 48 years (range 14-86 years). The group included 131 females (54%) and 110 males (46%). Seventy-six percent of the patients with pituitary tumors had microadenomas (diameter Ͻ 10 mm) and 24% had macroadenomas. The postoperative diagnoses for these patients were as follows: endocrine-inactive adenoma (50%), prolactinoma (12%), GH-secreting adenoma (12%), Cushing disease (9%), Rathke cleft cyst (9%), craniopharyngioma (1%), and other lesions (7%). Fat grafts were placed intraoperatively in 62% of the patients. The median hospital stay for this group of patients was 3 days.
Of these patients, 55 (23%) had sodium values consistent with hyponatremia. The degree of hyponatremia was mild (131-135 mEq/L) in 26 patients (11%), moderate (126-130 mEq/L) in 15 patients (6%), and severe (Յ 125 mEq/L) in 14 patients (6%). Eleven of the outpatients (20%) with demonstrable hyponatremia serum sodium level were or became symptomatic, and the remaining 44 (80%) remained asymptomatic. Seven of the 11 symptomatic outpatients had severe hyponatremia, three had moderate hyponatremia, and one had mild hyponatremia. Therefore, outpatients with moderate hyponatremia were five times as likely to be symptomatic than those with mild hyponatremia, and those with severe hyponatremia were 12.5 times as likely to be symptomatic ( Table 2 ). The mean serum sodium level on postoperative Day 7 in the asymptomatic, hyponatremic outpatients was 129.3 mEq/L, compared with 123.2 mEq/L in the symptomatic, hyponatremic outpatients (p = 0.005).
Asymptomatic patients with mild hyponatremia did not have blood drawn for routine follow-up analysis unless they subsequently became symptomatic. Nineteen patients with moderate or severe asymptomatic hyponatremia were asked to have blood drawn for repeated determination of serum sodium level after restricting fluids and following a highsodium diet. Although data on repeated laboratory analysis of sodium levels was obtained in only six cases, in which improvement of sodium levels was demonstrated by postoperative Day 11. All 11 symptomatic patients were readmitted to the hospital; three responded to fluid restriction and administration of salt tablets, whereas eight required intravenous administration of 3% NaCl in addition to fluid restriction. The median duration of hospital stay during rehospitalization was 2 days. Patients who required hypertonic NaCl therapy received an average of 33 hours of intravenous 3% NaCl at a rate of 30 to 40 ml/hour. All 11 patients responded to treatment and were discharged with normal sodium levels. No patients became hypernatremic or developed central pontine myelinolysis as a result of this treatment.
Overall Incidence of Hyponatremia
Of the total of 369 patients in this study (inpatients and outpatients), 103 patients (28%) developed delayed postoperative hyponatremia. The severity of hyponatremia was mild in 36 patients (10%), moderate in 31 patients (8%), and severe in 36 patients (10%). The mean postoperative sodium levels for various patient subgroups are displayed in Table 3 Risk factors for delayed hyponatremia are displayed in Table 4 . Female patients were more likely to develop hyponatremia than were male patients (33% compared with 22%, p = 0.027). Having had postoperative transient DI also placed patients at greater risk for the development of de- Delayed hyponatremia was also noted in 59% of patients in whom meningitis developed, and 44% of patients in whom cerebrospinal fluid leaks developed. These findings, however, were not statistically significant. In 11 cases, the diagnosis of hyponatremia could be attributed to a cause other than SIADH. Five patients were diagnosed with meningitis as well as hyponatremia. Four patients experienced hyponatremia while receiving DDAVP. Other causes included volume overload and cortisol deficiency, each in one patient. In all 11 patients, the serum sodium level normalized after the underlying cause of hyponatremia was corrected.
Twenty-nine patients (28% of all hyponatremic patients) developed symptomatic hyponatremia. The majority of these patients (69%) developed symptoms after they were discharged from the hospital, while the remainder (31%) were inpatients when hyponatremia was diagnosed. The most common presenting symptoms were headache (86%), nausea/vomiting (68%), anorexia (14%), abdominal pain (9%), and seizure (5%). The mean sodium level in symptomatic, hyponatremic patients at the time of diagnosis was 120.5 mEq/L (range 110-130 mEq/L), compared with a mean sodium level of 128.4 mEq/L (range 113-134 mEq/L) in asymptomatic, hyponatremic patients (p Ͻ 0.0001). Seventy-nine percent of symptomatic patients had severely low sodium levels (Յ 125 mEq/L); 21% had mild or moderate hyponatremia (Fig. 1) .
Diabetes Insipidus
Symptoms and laboratory values consistent with DI developed in 33 patients (9%). Of these 33 patients, 31 were treated with DDAVP, while the other two compensated sufficiently by drinking to satiety. Eight patients (2%) developed persistent DI, defined by having a requirement for DDAVP at the time of discharge.
Patients who developed postoperative DI had a 48% risk of subsequently developing hyponatremia, compared with a 26% risk in the group of patients who had never had DI (p Ͻ 0.01). Seventeen (17%) of the 103 cases of hyponatremia were preceded by an episode of DI, compared with an overall incidence rate of DI of 9% in all patients. In four cases (1.1%), there was a postoperative trend in sodium levels that was consistent with a true triphasic response. Thirteen patients (3.5%) developed a biphasic response but never showed progression to persistent DI (Table 5 ).
Discussion
The results of this study corroborate the findings of previous studies that have demonstrated that delayed hyponatremia is relatively common in patients who have undergone transsphenoidal surgery.
2,5,9,11 The overall incidence rate (for both inpatients and outpatients) of delayed hyponatremia in the current series was 28%. On postoperative Day 7 after transsphenoidal surgery, 23% of the 241 outpatients who underwent random assessment of postoperative sodium levels were found to be hyponatremic. The lower incidence of hyponatremia in outpatients probably reflects the fact that patients with longer postoperative stays generally had more complicated postoperative courses, placing them at increased risk for hyponatremia. Twenty percent of hyponatremic outpatients (5% of all outpatients) had or developed symptoms resulting from hyponatremia. Therefore, four out of five outpatients found to have hyponatremia on routine testing had occult, asymptomatic hyponatremia, suggesting that symptoms would never develop or had not yet developed. Although the 5% incidence rate of symptomatic hyponatremia observed in outpatients is consistent with the incidence of symptomatic hyponatremia reported in previous series, 6, 7, 13 our findings reveal that occult, asymptomatic hyponatremia occurring in an outpatient setting is more common than has been previously suspected.
The incidence of hyponatremia reported in the current study is higher than that reported in some previous series of patients who underwent transsphenoidal surgery. The major difference between these studies is that our study accounts for patients with asymptomatic hyponatremia, whereas previous studies have only reported rates for patients presenting with symptomatic hyponatremia. Furthermore, we defined hyponatremia as a serum sodium value of less than 135 mEq/L, whereas other studies have used lower, less-inclusive thresholds. We selected this more-inclusive threshold (135 mEq/L) for defining hyponatremia because this was the lower limit used at our institution's laboratory, based on a normal serum sodium value range determined from healthy controls. Furthermore, one objective of our study was to include patients with laboratory-defined, yet clinically silent hyponatremia. Symptoms of hyponatremia generally develop when the sodium level falls below 130 mEq/L. Other studies may have selected threshold values lower than 135 mEq/L to improve the likelihood of identifying symptomatic patients. Finally, we included all causes of delayed hyponatremia in our study, whereas other studies have excluded patients with hyponatremia of known causes other than SIADH.
Outpatient Screening for Hyponatremia
After routine discharge from the hospital, evaluating patients' serum sodium levels on an outpatient basis on postoperative Day 7 appears to be an effective way of identifying patients with hyponatremia and potentially preventing the onset of symptoms. Outpatients with severe hyponatremia (Na Յ 125 mEq/L) on postoperative Day 7 were over 12 times as likely to be symptomatic as patients with mild hyponatremia. This study supports the treatment of asymptomatic mild or moderate hyponatremia with outpatient fluid restriction and a high-sodium diet. Patients can then be monitored by having their sodium values assessed every 2 days until their sodium levels normalize. Management should also be based on clinical status, because some patients with sodium levels as high as 130 mEq/L were symptomatic, and others with sodium levels as low as 113 mEq/L remained asymptomatic. Patients should be advised at the time of discharge to contact their physician if they develop symptoms such as headaches, nausea, or vomiting.
Risk Factors for Delayed Hyponatremia
In the current study, only sex and prior development of transient DI correlated with the incidence of delayed hyponatremia. Female patients showed a greater propensity for developing delayed hyponatremia than did males (33% compared with 22%, p = 0.027). Furthermore, female patients were almost three times as likely to develop severe hyponatremia than male patients were (14% compared with 4%, p = 0.001). Higher incidence rates of hyponatremia in female patients have been previously reported by Sane and colleagues. 11 In our series, the incidence of delayed hyponatremia was more than twice as high in patients who had transient DI earlier in their postoperative course compared with those who did not (48% compared with 21%, p Ͻ 0.01). In a large case series reported by Taylor and coauthors, 13 36% of patients with delayed hyponatremia had previously experienced DI. Similarly, Sane and associates 11 demonstrated that 36% of patients with DI went on to develop hyponatremia, compared with 28% in the non-DI group. Finally, Hensen et al. 6 observed that 40% of patients with delayed hyponatremia required DDAVP prior to the onset of hyponatremia.
Our study did not reveal any significant difference in the onset of hyponatremia between the microadenoma and macroadenoma groups, although there was a trend for patients with microadenomas to develop severe hyponatremia (11% compared with 6%). This finding did not prove to be statistically significant (p = 0.21). On the other hand, Kelly and colleagues 7 found a higher incidence of hyponatremia in patients who had undergone resection of macroadenomas, whereas Sane et al. 11 determined that patients with microadenomas were more likely to develop hyponatremia. Other authors 6, 9 have postulated that microadenomas may present a greater risk factor for hyponatremia because of the higher degree of gland exploration required to identify and resect these lesions.
Tumor cell type did not predict incidence of hyponatremia in our series, although tumor type did correlate with the severity of hyponatremia. Patients with Rathke cleft cysts and Cushing disease had significantly lower postoperative sodium levels than hyponatremic patients with other tumor types. Patients with Rathke cleft cysts who developed hyponatremia had a mean serum sodium value of 119 mEq/L, compared with a mean serum sodium value of 129.8 mEq/L in acromegalic patients who developed hyponatremia (p Ͻ 0.03). Higher incidences of hyponatremia in patients with Cushing disease have also been reported in two previous studies. 6, 11 Taylor and colleagues 13 found that patients with nonfunctional tumors had a higher risk of developing hyponatremia. In the current study, acromegalic patients appeared to be at lower risk for developing hyponatremia, as only 2% of these patients developed severe hyponatremia. However, this finding was not statistically significant.
Etiology of Hyponatremia
There are a number of potential causes of hyponatremia in patients who have undergone pituitary surgery that should be considered in the differential diagnosis.The most common cause of delayed postoperative hyponatremia is SIADH. Other potential causes of hyponatremia in patients who have undergone pituitary surgery include hypocortisolemia, volume overload, overadministration of DDAVP, and hypothyroidism. Less likely causes such as other medications and cerebral salt wasting have also been reported but occur much less frequently. 1, 11, 12 For hyponatremia occurring on postoperative Days 1 through 3, cortisol deficiency or fluid overload should be strongly considered. 12 Eleven patients in the current study had other identifiable causes of delayed hyponatremia, including meningitis, fluid overload, or hypocortisolemia. Four of the patients in our study developed delayed hyponatremia while taking DDAVP. One limitation of our study is that the cause of hyponatremia in our patients was not always clearly defined, and the diagnosis of SIADH was often one of exclusion.
Fluctuations in serum sodium levels have been reported to occur in a predictable triphasic pattern based on physiological experimentation and clinical observation. 15 A short phase of DI (polyuria, polydipsia, and hypernatremia) tends to occur within the first 2 to 3 days after surgical manipulation of the pituitary gland. The second phase occurs approximately 7 days postoperatively, and is characterized by a phase of hyponatremia and euvolemia (SIADH). Finally, there is a recurrence of DI that may be persistent or transient. In our study, four (50%) of the eight patients who developed persistent DI exhibited both previous transient DI and hyponatremia. Only 1.1% of patients demonstrated a classic triphasic response, whereas 3.5% of patients demonstrated a biphasic response. Data from previous studies 6, 13 have also suggested that this clinical triad is not particularly consistent, with approximately 1% of patients exhibiting evidence of this pattern of ADH secretion. The reason for this experimental and clinical discrepancy is unknown, but is likely a reflection of clinical intervention as opposed to strict observation in the experimental setting.
Conclusions
Delayed hyponatremia occurs frequently after transsphenoidal surgery, more often than has been previously suspected. The majority of patients with delayed hyponatremia have asymptomatic hyponatremia. Female patients and patients who have had previous transient DI have a higher risk of developing delayed hyponatremia. Obtaining a serum sodium value on an outpatient basis 1 week after surgery is beneficial in diagnosing, stratifying, and allowing for early, preventive correction of hyponatremia.
